DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

company name or ticker
Company Photos
(Click to zoom)

Merck & Co., Inc. Falters After Q4 Report

Gilead (GILD) Beats Q4 Earnings Estimates, Gives 2016 View

Merk (MRK) Earnings Report: Q4 2015 Conference Call Transcript

International Growth Propels Gilead Sciences Inc.'s Solid Q4 Results

The big biotech overcame a tough U.S. environment for its hepatitis C drugs to succeed in the fourth quarter.

3 Stocks Pulling The Drugs Industry Downward

Dow Movers: INTC, DD

Health Care Sector Update for 02/03/2016: TRIL, MRK

Merck Trips Up Over Mixed Earnings

Shares Of Merck Dip Lower Following Q4 Print

UPDATE 1-Merck's revenue misses on lower drug sales, strong dollar

See More Articles...